IHH invests in Belun Technology for AI-powered sleep diagnostic technology

IHH will utilise Belun’s medical-grade device for sleep apnea detection.

IHH Healthcare has invested in Belun Technology to utilise the company’s AI-powered device for detecting and diagnosing sleep apnea and other sleep disorders.

IHH aims to make diagnosis more convenient and accessible for patients with Belun’s medical-grade wearable ring device, cleared by the US Food and Drug Administration (FDA).

Moreover, the device will assist physicians and sleep specialists in better understanding a patient’s sleep stages for the formulation of a personalised treatment plan.

ALSO READ: SGH and NNI study reveals connection between scoliosis and brainstem

“Our investment in Belun underscores our commitment to enhancing care and services to our patients through the strategic adoption of AI and other innovative technologies,” Prem Kumar Nair, Group Chief Executive Officer of IHH Healthcare, said.

“By partnering with promising ventures, we are expanding our capabilities and creating value across the healthcare continuum,” Nair added.

IHH plans to explore further collaboration with Belun to address other health conditions associated with sleep disorders.